Monopar Therapeutics Inc. (MNPR) Latest News

NASDAQ Currency in USD Disclaimer

Stock Price

$15.69

-$1.28

(-7.49%)

Day's range

$15.51

$16.61

Latest News of MNPR

Up 600% Then Down 50% In 2 Days: What Is Going On With MNPR Stock?

By Forbes | 1 week ago

Monopar Therapeutics' stock (NASDAQ: MNPR) surged due to a licensing deal with Alexion for a promising drug to treat Wilson Disease. MNPR also showed positive results in its pipeline. The stock correc...

Monopar Therapeutics Inc. (MNPR) Stock Price, News, Quote & History - Yahoo Finance

By Yahoo! Finance | 1 week ago

Monopar Therapeutics has partnered with Alexion, AstraZeneca Rare Disease for the exclusive global license of ALXN-1840, a drug for Wilson disease. This agreement comes after successful Phase 3 trials...

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.